Abstract
The awareness of general practitioners of selected adverse drug interactions has been assessed. The drugs studied included adrenergic neurone blockers, warfarin, antidiabetic agents, and monoamine oxidase inhibitors. The findings must be interpreted with caution but they suggest that there is a clear need to improve the effectiveness of communication of information about adverse drug interactions if unnecessary iatrogenic disease is to be avoided.
Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Beveridge T., Petrie J. C. Transfer of information about intake of drugs by patients referred to medical units. Br Med J. 1972 Apr 1;2(5804):37–39. doi: 10.1136/bmj.2.5804.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gulati O. D., Dave B. T., Gokhale S. D., Shah K. M. Antagonism of adrenergic neuron blockade in hypertensive subjects. Clin Pharmacol Ther. 1966 Jul-Aug;7(4):510–514. doi: 10.1002/cpt196674510. [DOI] [PubMed] [Google Scholar]
- LEISHMAN A. W., MATTHEWS H. L., SMITH A. J. Anatgonism of guanethidine by imipramine. Lancet. 1963 Jan 12;1(7272):112–112. doi: 10.1016/s0140-6736(63)91123-1. [DOI] [PubMed] [Google Scholar]
- Mitchell J. R., Cavanaugh J. H., Arias L., Oates J. A. Guanethidine and related agents. 3. Antagonism by drugs which inhibit the norepinephrine pump in man. J Clin Invest. 1970 Aug;49(8):1596–1604. doi: 10.1172/JCI106377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sjöqvist F. Psychotropic drugs (2). Interaction between monoamine oxidase (MAO) inhibitors and other substances. Proc R Soc Med. 1965 Nov;58(11 Pt 2):967–978. doi: 10.1177/003591576505811P206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Starr K. J., Petrie J. C. Drug interactions in patients on long-term oral anticoagulant and antihypertensive adrenergic neuron-blocking drugs. Br Med J. 1972 Oct 21;4(5833):133–135. doi: 10.1136/bmj.4.5833.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
